查看購物車
  • English
  • Japanese
  • Korean
本報告分析了粘菌素市場規模及預測（2021-2034年），包括全球及區域市場佔有率、趨勢和成長機會。報告涵蓋以下幾個面向：劑型、適應症、通路和地區。
市場調查報告書
商品編碼
2021158

本報告分析了粘菌素市場規模及預測（2021-2034年），包括全球及區域市場佔有率、趨勢和成長機會。報告涵蓋以下幾個面向：劑型、適應症、通路和地區。

Colistin Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Formulation, Indication, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 346 Pages | 訂單完成後即時交付

價格
預計粘菌素市場規模將從2025年的3.37億美元成長到2034年的5.1094億美元，2026年至2034年的複合年成長率（CAGR）為4.8%。醫療保健領域多重抗藥性革蘭氏陰性病菌感染的日益普遍，以及畜禽養殖業持續的獸醫需求，是推動粘菌素市場成長的重要因素。此外，新型製劑和給藥系統的進步，以及聯合治療的日益普及，預計將在不久的將來引領新的市場趨勢。

新型製劑和遞送系統的進展包括脂質體黏菌素的開發，它透過包裹藥物來降低腎毒性並改善標靶遞送，尤其是在全身性性行為感染。例如，人們正在探索脂質體製劑，以拓展傳統注射劑以外的治療選擇，吸入劑和外用製劑在感染疾病和局部感染疾病的治療中日益受到關注。大規模臨床試驗評估了新型黏菌素製劑的聯合治療，結果表明，在重症病例中，聯合療法可改善治療效果。高純度硫酸粘菌素佔據了主要市場佔有率，這主要得益於其在治療和研究方面的應用。在慢性肺部感染疾病，2023年全球透過霧化器和局部給藥途徑進行的黏菌素臨床試驗增加，重點在於囊腫纖維化和人工呼吸器相關性肺炎等疾病。奈米技術的進步旨在增強黏菌素的活性並提高藥物滲透性，從而降低抗藥性產生的可能性。這些創新有望維持在替代療法有限的特定應用領域的需求，尤其是在亞太等感染率高的地區，由於醫療基礎設施的不斷完善，預計這些地區將佔據相當大的市場佔有率。此外，動態療法 (PDT) 正被用作輔助性治療，以增強粘菌素對抗藥性菌株的療效。總體而言，旨在降低毒性、提高生物利用度和增強對多重抗藥性感染疾病療效的新型製劑和遞送系統的創新，預計將成為未來幾年的主要發展趨勢。

按分銷管道分類的洞察

根據分銷管道，粘菌素市場可分為醫院藥房、零售藥房、線上通路和其他分銷管道。預計到2025年，醫院藥局將佔據最大的市場佔有率。醫院藥局是粘菌素在醫療保健領域的主要分銷管道，尤其在加護病房（ICU）治療嚴重革蘭氏陰性病菌感染發揮著至關重要的作用。在ICU中，粘菌素通常透過靜脈注射或吸入給藥，用於治療人工呼吸器相關性肺炎和敗血症等疾病。例如，甲磺酸磺酸鹽菌素常被列入醫院處方集，作為對抗鮑曼鮑氏不動桿菌桿菌和銅綠假單胞菌等病原體的最後防線，其給藥方案會根據腎功能進行調整，以降低腎毒性。 2023年，醫院藥局協助治療了超過320萬例需要使用多粘菌素類抗生素的ICU相關感染疾病。在巴西、印尼和俄羅斯等國家，超過37%的重症病例對碳青黴烯類抗生素有抗藥性，這推高了對粘菌素的需求。一項研究表明，約60%的人用粘菌素是透過醫院通路分銷的，這得益於Xellia Pharmaceuticals和Fresenius Kabi等生產商的直接採購。醫院擴大採用聯合治療，這在提高療效的同時，也能透過適當的藥物使用計畫監測用藥情況，從而防止抗藥性菌株的產生。在歐洲，歐洲藥品管理局（EMA）負責監管醫院的粘菌素供應，確保製劑的高純度。 Hikma Pharmaceuticals和Teva Pharmaceutical Industries等主要企業透過合約合作關係進行供應，強調在法律規範內維持供應鏈的韌性。由於粘菌素在急性治療中發揮著至關重要的作用，因此該管道佔據主導地位，但人們對其毒性的擔憂限制了其在門診環境中的廣泛應用。

目錄

第1章：執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：粘菌素市場現狀

  • 價值鏈分析
    • 原料供應商/零件
    • 製造商/製造流程/技術
    • 經銷概覽
    • 最終用戶
    • 整合程度
  • 供應鏈分析
    • 製造商/供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • 波特五力分析
    • 供應商議價能力：中等
    • 買方議價能力：高
    • 新進入者的威脅：中等
    • 替代品威脅：高
    • 競爭公司之間的競爭程度：高
  • PEST分析
  • 永續發展與ESG趨勢
    • 永續發展趨勢
    • 環境趨勢
    • 社會趨勢
    • 管治趨勢
  • 法律規範
  • 市場准入壁壘
    • 監管方面
    • 競爭方面
    • 還款相關方面
  • CMS 與硫酸粘菌素—生產和商業性評估
  • 全球競標分析
  • 三大疾病的流行情況（按地區分類，2024 年）
  • 價格分析，主要產品的平均售價（ASP）
  • 2025年全球粘菌素原料藥市場規模（噸）
  • 下一代多粘菌素製劑的研發管線分析

第3章 競爭情勢

  • 主要企業的基準
  • 市佔率分析（%），2025 年
  • 市場集中度

第4章：粘菌素市場－主要產業趨勢

  • 市場促進因素
    • 人類醫療保健領域中多重抗藥性革蘭氏陰性病菌感染的增加。
    • 畜牧和家禽業對獸醫服務的持續需求
    • 應對抗生素抗藥性的監管變革和政策
  • 市場限制因素
    • 限制臨床環境中應用的因素
    • 粘菌素抗藥性日益普遍
    • 嚴格的監管政策和使用禁令
  • 市場機遇
    • 吸入式粘菌素製劑在呼吸道感染疾病的進展
    • 擴大多重抗藥性感染疾病的聯合治療
    • 亞太地區市場擴張受抗生素抗藥性日益增強的推動。
  • 未來趨勢
    • 新型製劑和遞送系統的進展
    • 聯合治療和協同療法的增加
    • 加強合理使用抗生素的法規結構
  • 促進因素和抑制因素的影響

第5章：粘菌素市場－全球市場分析

  • 2021-2034年粘菌素市場銷售額
  • 粘菌素市場預測與分析

第6章：粘菌素市場收入分析－以劑型分類

  • 粘菌素市場預測及製劑分析
    • 口服
      • 口服：粘菌素市場 - 銷售收入，2021-2034 年
    • 注射藥物（靜脈注射或肌肉注射）
      • 注射用藥物（靜脈注射或肌肉注射）：粘菌素市場 - 銷售收入，2021-2034 年
    • 外用製劑
      • 外用製劑：粘菌素市場 - 銷售收入，2021-2034 年
    • 吸入劑
      • 吸入劑：粘菌素市場 - 銷售收入，2021-2034 年

第7章：粘菌素市場收入分析－依適應症分類

  • 按適應症分類的粘菌素市場預測與分析
    • 動物用藥品
      • 動物用藥品：粘菌素市場 - 銷售收入，2021-2034 年
    • 人類健康
      • 人用藥品：粘菌素市場 - 銷售收入，2021-2034 年

第8章：粘菌素市場收入分析－通路

  • 按分銷管道分類的粘菌素市場預測和分析
    • 醫院藥房
      • 醫院藥局：粘菌素市場 - 銷售收入，2021-2034 年
    • 零售藥房
      • 零售藥局：粘菌素市場 - 銷售收入，2021-2034 年
    • 線上管道
      • 線上通路：粘菌素市場 - 銷售收入，2021-2034 年
    • 其他分銷管道
      • 其他通路：粘菌素市場 - 銷售收入，2021-2034 年

第9章：粘菌素市場－區域分析

  • 北美洲
    • 劑型
    • 適應症
    • 分銷管道
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 英國市場
    • 法國市場
    • 義大利市場
    • 西班牙市場
    • 波蘭市場
    • 羅馬尼亞市場
    • 塞爾維亞市場
    • 保加利亞市場
    • 捷克市場
    • 比利時市場
    • 斯洛伐克市場
    • 愛爾蘭市場
    • 匈牙利市場
    • 葡萄牙市場
    • 立陶宛市場
    • 奧地利市場
    • 波斯尼亞市場
    • 拉脫維亞市場
    • 荷蘭市場
    • 希臘市場
    • 其他歐洲市場
  • 亞太地區
    • 澳洲和紐西蘭市場
    • 日本市場
    • 哈薩克市場
    • 亞太地區的其他國家
  • 中東和非洲
    • 沙烏地阿拉伯市場
    • 其他中東和非洲市場
  • 中美洲和南美洲
    • 巴西市場
    • 南美洲和中美洲的其他市場

第10章：粘菌素市場的產業趨勢

第11章：粘菌素市場－主要企業概況

  • Hebei Shengxue Dacheng Pharmaceutical Co., Ltd
  • Norma Hellas SA
  • Apeloa Pharmaceutical Co., Ltd.
  • Livzon Pharmaceutical Group Inc
  • Shandong LuKang Pharmaceutical Co., Ltd
  • Xellia Pharmaceuticals ApS
  • Zhejiang Shenghua Biok Chemical Company Limited
  • Fujian lifecome biochemistry Limited
  • Tecoland Corporation
  • TZF Polfa SA

第12章附錄

Product Code: TIPRE00042707

The Colistin market size is expected to grow from US$ 337.00 million in 2025 to US$ 510.94 million by 2034; it is projected to register a CAGR of 4.8% during 2026-2034. The increased multidrug-resistant Gram-negative infections in human healthcare, sustained veterinary demand in livestock and poultry farming are noteworthy factors contributing to the expansion of the colistin market. Additionally, the advancements in novel formulations and delivery systems as well as a rise in combination and synergistic therapies are projected to bring new market drifts in the near future.

The advancement in novel formulations and delivery systems includes the development of liposomal colistin, which encapsulates the drug to reduce nephrotoxicity and improve targeted delivery, particularly for systemic infections. For instance, liposomal formulations are being explored to broaden treatment options beyond traditional injectables, with inhalable and topical preparations gaining traction for respiratory and localized infections. A large-scale clinical trial launched in 2022 evaluated novel colistin formulations in combination therapies, demonstrating improved outcomes in severe cases. The high-purity colistin sulfate segment holds a major share, driven by therapeutic and research applications. In chronic lung infections, nebulized and topical colistin delivery experienced an increase in global clinical trials in 2023, focusing on conditions such as cystic fibrosis and ventilator-associated pneumonia. Advancements in nanotechnology are focused on enhancing colistin's activity, reducing the likelihood of resistance through improved drug penetration. These innovations are expected to sustain demand in niche applications where alternatives are limited, particularly in high-burden regions such as Asia Pacific, which anticipates a major share owing to expanding healthcare infrastructure. Photodynamic therapy (PDT) as an adjunctive method is also being integrated to boost colistin's effectiveness against resistant strains. Overall, innovations in novel formulations and delivery systems aimed at minimizing toxicity, improving bioavailability, and enhancing efficacy against multidrug-resistant infections are expected to be the key trends in the coming years.

Distribution Channel -Based Insights

Based on distribution channel, the colistin market is segmented into hospital pharmacy, retail pharmacy, online channel, and other distribution channel. The hospital pharmacy segment held the largest market share in 2025. Hospital pharmacies serve as the primary distribution channel for colistin in human healthcare, particularly for treating severe multidrug-resistant Gram-negative infections in intensive care settings, where the drug is administered intravenously or via inhalation for conditions like ventilator-associated pneumonia and sepsis. For example, colistin methanesulfonate is commonly stocked in hospital formularies for last-resort use against pathogens such as Acinetobacter baumannii and Pseudomonas aeruginosa, with dosing protocols adjusted for renal function to mitigate nephrotoxicity. In 2023, hospital pharmacies facilitated treatments for over 3.2 million ICU-related infections requiring polymyxin-class antibiotics, with countries like Brazil, Indonesia, and Russia reporting over 37% of severe cases resistant to carbapenems, driving demand. A study indicated that hospital channels account for approximately 60% of colistin distribution in human medicine, supported by direct procurement from manufacturers like Xellia Pharmaceuticals and Fresenius Kabi. Trends show increasing adoption of combination therapies in hospitals, enhancing efficacy while stewardship programs monitor usage to curb resistance. In Europe, the European Medicines Agency regulates hospital supplies, ensuring high-purity formulations. Key players such as Hikma Pharmaceuticals and Teva Pharmaceutical Industries supply through contractual collaborations, emphasizing supply chain resilience amid regulatory frameworks. This channel's dominance stems from colistin's role in acute care, though toxicity concerns limit broader outpatient shifts.

The World Health Organization, Centers for Disease Control and Prevention (CDC), Pan-Canadian Action Plan on Antimicrobial Resistance, European Centre for Disease Prevention and Control (ECDC), UK Health Security Agency (UKHSA), Agency for Health and Food Safety, the National Public Health Organization, Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report, the Australia and New Zealand Group on Antimicrobial Resistance (AGAR), the Ministry of Health, and Labour and Welfare (MHLW) are among the primary and secondary sources referred to while preparing the colistin market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Colistin Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
    • 2.2.1 Raw Material Suppliers / Components
    • 2.2.2 Manufacturers/ Process / Technology
    • 2.2.3 Distribution Landscape
    • 2.2.4 End User
    • 2.2.5 Level of Integration
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
    • 2.4.1 Bargaining Power of Suppliers: Moderate
    • 2.4.2 Bargaining Power of Buyers: High
    • 2.4.3 Threat of New Entrants: Moderate
    • 2.4.4 Threat of Substitutes: High
    • 2.4.5 Competitive Rivalry: High
  • 2.5 PEST Analysis
  • 2.6 Sustainability and ESG Trends
    • 2.6.1 Sustainability Trends
    • 2.6.2 Environmental Trends
    • 2.6.3 Social Trends
    • 2.6.4 Governance Trends
  • 2.7 Regulatory Framework
  • 2.8 Market Entry Barriers
    • 2.8.1 Regulatory Aspect
    • 2.8.2 Competitive Aspect
    • 2.8.3 Reimbursement-Related Aspect
  • 2.9 CMS Vs Colistin Base Sulphate - Manufacturing & Commercial Assessment
  • 2.10 Global Tender Analysis
  • 2.11 Prevalence of Key 3 Diseases, By Region, 2024
  • 2.12 Pricing Analysis, ASPs of Key Products
  • 2.13 Global Colistin API Market Volume (Tonnes), 2025
  • 2.14 Pipeline Analysis of Next-Generation Polymyxins

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis (%), 2025
  • 3.3 Market Concentration

4. Colistin Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increased Multidrug-Resistant Gram-Negative Infections in Human Healthcare:
    • 4.1.2 Sustained Veterinary Demand in Livestock and Poultry Farming
    • 4.1.3 Regulatory Shifts and Policies Addressing Antimicrobial Resistance
  • 4.2 Market Restraints
    • 4.2.1 Limiting Clinical Adoption
    • 4.2.2 Increased Prevalence of Colistin Resistance
    • 4.2.3 Stringent Regulatory Policies and Bans
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Inhaled Colistin Formulations for Respiratory Infections
    • 4.3.2 Expansion of Combination Therapies for Multidrug-Resistant Infections
    • 4.3.3 Regional Market Expansion in Asia Pacific Amid Rising Antimicrobial Resistance
  • 4.4 Future Trends
    • 4.4.1 Advancements in Novel Formulations and Delivery Systems
    • 4.4.2 Rise in Combination and Synergistic Therapies
    • 4.4.3 Enhanced Antimicrobial Stewardship and Regulatory Frameworks
  • 4.5 Impact of Drivers and Restraints

5. Colistin Market - Global Market Analysis

  • 5.1 Colistin Market Revenue (US$ Million), 2021-2034
  • 5.2 Colistin Market Forecast and Analysis

6. Colistin Market Revenue Analysis - Formulation

  • 6.1 Colistin Market Forecasts and Analysis by Formulation
    • 6.1.1 Oral
      • 6.1.1.1 Overview
      • 6.1.1.2 Oral: Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Injectables (IV or IM)
      • 6.1.2.1 Overview
      • 6.1.2.2 Injectables (IV or IM): Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Topical Formulations
      • 6.1.3.1 Overview
      • 6.1.3.2 Topical Formulations: Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.4 Inhalation Solutions
      • 6.1.4.1 Overview
      • 6.1.4.2 Inhalation Solutions: Colistin Market - Revenue, 2021-2034 (US$ Million)

7. Colistin Market Revenue Analysis - Indication

  • 7.1 Colistin Market Forecasts and Analysis by Indication
    • 7.1.1 Animal Health
      • 7.1.1.1 Overview
      • 7.1.1.2 Animal Health Health: Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Human Health
      • 7.1.2.1 Overview
      • 7.1.2.2 Human Health: Colistin Market - Revenue, 2021-2034 (US$ Million)

8. Colistin Market Revenue Analysis - Distribution Channel

  • 8.1 Colistin Market Forecasts and Analysis by Distribution Channel
    • 8.1.1 Hospital Pharmacy
      • 8.1.1.1 Overview
      • 8.1.1.2 Hospital Pharmacy: Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Retail Pharmacy
      • 8.1.2.1 Overview
      • 8.1.2.2 Retail Pharmacy: Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Online Channel
      • 8.1.3.1 Overview
      • 8.1.3.2 Online Channel: Colistin Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Other Distribution Channel
      • 8.1.4.1 Overview
      • 8.1.4.2 Other Distribution Channel: Colistin Market - Revenue, 2021-2034 (US$ Million)

9. Colistin Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Colistin Market Overview
    • 9.1.2 North America: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.1.3 North America: Colistin Market - By Segmentation
      • 9.1.3.1 Formulation
      • 9.1.3.2 Indication
        • 9.1.3.2.1 Human Health
      • 9.1.3.3 Distribution Channel
    • 9.1.4 North America: Colistin Market Breakdown by Countries
      • 9.1.4.1 United States Market
        • 9.1.4.1.1 United States: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.1.2 United States: Colistin Market - By Segmentation
          • 9.1.4.1.2.1 Formulation
          • 9.1.4.1.2.2 Indication
            • 9.1.4.1.2.2.1 Human Health
          • 9.1.4.1.2.3 Distribution Channel
      • 9.1.4.2 Canada Market
        • 9.1.4.2.1 Canada: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.2.2 Canada: Colistin Market - By Segmentation
          • 9.1.4.2.2.1 Formulation
          • 9.1.4.2.2.2 Indication
            • 9.1.4.2.2.2.1 Human Health
          • 9.1.4.2.2.3 Distribution Channel
      • 9.1.4.3 Mexico Market
        • 9.1.4.3.1 Mexico: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.3.2 Mexico: Colistin Market - By Segmentation
          • 9.1.4.3.2.1 Formulation
          • 9.1.4.3.2.2 Indication
            • 9.1.4.3.2.2.1 Human Health
          • 9.1.4.3.2.3 Distribution Channel
  • 9.2 Europe
    • 9.2.1 Europe Colistin Market Overview
    • 9.2.2 Europe: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.2.3 Europe: Colistin Market - By Segmentation
      • 9.2.3.1 Formulation
      • 9.2.3.2 Indication
        • 9.2.3.2.1 Human Health
      • 9.2.3.3 Distribution Channel
    • 9.2.4 Europe: Colistin Market Breakdown by Countries
      • 9.2.4.1 Germany Market
        • 9.2.4.1.1 Germany: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.1.2 Germany: Colistin Market - By Segmentation
          • 9.2.4.1.2.1 Formulation
          • 9.2.4.1.2.2 Indication
            • 9.2.4.1.2.2.1 Human Health
          • 9.2.4.1.2.3 Distribution Channel
      • 9.2.4.2 United Kingdom Market
        • 9.2.4.2.1 United Kingdom: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.2.2 United Kingdom: Colistin Market - By Segmentation
          • 9.2.4.2.2.1 Formulation
          • 9.2.4.2.2.2 Indication
            • 9.2.4.2.2.2.1 Human Health
          • 9.2.4.2.2.3 Distribution Channel
      • 9.2.4.3 France Market
        • 9.2.4.3.1 France: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.3.2 France: Colistin Market - By Segmentation
          • 9.2.4.3.2.1 Formulation
          • 9.2.4.3.2.2 Indication
            • 9.2.4.3.2.2.1 Human Health
          • 9.2.4.3.2.3 Distribution Channel
      • 9.2.4.4 Italy Market
        • 9.2.4.4.1 Italy: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.4.2 Italy: Colistin Market - By Segmentation
          • 9.2.4.4.2.1 Formulation
          • 9.2.4.4.2.2 Indication
            • 9.2.4.4.2.2.1 Human Health
          • 9.2.4.4.2.3 Distribution Channel
      • 9.2.4.5 Spain Market
        • 9.2.4.5.1 Spain: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.5.2 Spain: Colistin Market - By Segmentation
          • 9.2.4.5.2.1 Formulation
          • 9.2.4.5.2.2 Indication
            • 9.2.4.5.2.2.1 Human Health
          • 9.2.4.5.2.3 Distribution Channel
      • 9.2.4.6 Poland Market
        • 9.2.4.6.1 Poland: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.6.2 Poland: Colistin Market - By Segmentation
          • 9.2.4.6.2.1 Formulation
          • 9.2.4.6.2.2 Indication
            • 9.2.4.6.2.2.1 Human Health
          • 9.2.4.6.2.3 Distribution Channel
      • 9.2.4.7 Romania Market
        • 9.2.4.7.1 Romania: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.7.2 Romania: Colistin Market - By Segmentation
          • 9.2.4.7.2.1 Formulation
          • 9.2.4.7.2.2 Indication
            • 9.2.4.7.2.2.1 Human Health
          • 9.2.4.7.2.3 Distribution Channel
      • 9.2.4.8 Serbia Market
        • 9.2.4.8.1 Serbia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.8.2 Serbia: Colistin Market - By Segmentation
          • 9.2.4.8.2.1 Formulation
          • 9.2.4.8.2.2 Indication
            • 9.2.4.8.2.2.1 Human Health
          • 9.2.4.8.2.3 Distribution Channel
      • 9.2.4.9 Bulgaria Market
        • 9.2.4.9.1 Bulgaria: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.9.2 Bulgaria: Colistin Market - By Segmentation
          • 9.2.4.9.2.1 Formulation
          • 9.2.4.9.2.2 Indication
            • 9.2.4.9.2.2.1 Human Health
          • 9.2.4.9.2.3 Distribution Channel
      • 9.2.4.10 Czech Republic Market
        • 9.2.4.10.1 Czech Republic: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.10.2 Czech Republic: Colistin Market - By Segmentation
          • 9.2.4.10.2.1 Formulation
          • 9.2.4.10.2.2 Indication
            • 9.2.4.10.2.2.1 Human Health
          • 9.2.4.10.2.3 Distribution Channel
      • 9.2.4.11 Belgium Market
        • 9.2.4.11.1 Belgium: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.11.2 Belgium: Colistin Market - By Segmentation
          • 9.2.4.11.2.1 Formulation
          • 9.2.4.11.2.2 Indication
            • 9.2.4.11.2.2.1.1 Human Health
          • 9.2.4.11.2.3 Distribution Channel
      • 9.2.4.12 Slovakia Market
        • 9.2.4.12.1 Slovakia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.12.2 Slovakia: Colistin Market - By Segmentation
          • 9.2.4.12.2.1 Formulation
          • 9.2.4.12.2.2 Indication
            • 9.2.4.12.2.2.1 Human Health
          • 9.2.4.12.2.3 Distribution Channel
      • 9.2.4.13 Ireland Market
        • 9.2.4.13.1 Ireland: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.13.2 Ireland: Colistin Market - By Segmentation
          • 9.2.4.13.2.1 Formulation
          • 9.2.4.13.2.2 Indication
            • 9.2.4.13.2.2.1 Human Health
          • 9.2.4.13.2.3 Distribution Channel
      • 9.2.4.14 Hungary Market
        • 9.2.4.14.1 Hungary: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.14.2 Hungary: Colistin Market - By Segmentation
          • 9.2.4.14.2.1 Formulation
          • 9.2.4.14.2.2 Indication
            • 9.2.4.14.2.2.1 Human Health
          • 9.2.4.14.2.3 Distribution Channel
      • 9.2.4.15 Portugal Market
        • 9.2.4.15.1 Portugal: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.15.2 Portugal: Colistin Market - By Segmentation
          • 9.2.4.15.2.1 Formulation
          • 9.2.4.15.2.2 Indication
            • 9.2.4.15.2.2.1 Human Health
          • 9.2.4.15.2.3 Distribution Channel
      • 9.2.4.16 Lithuania Market
        • 9.2.4.16.1 Lithuania: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.16.2 Lithuania: Colistin Market - By Segmentation
          • 9.2.4.16.2.1 Formulation
          • 9.2.4.16.2.2 Indication
            • 9.2.4.16.2.2.1 Human Health
          • 9.2.4.16.2.3 Distribution Channel
      • 9.2.4.17 Austria Market
        • 9.2.4.17.1 Austria: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.17.2 Austria: Colistin Market - By Segmentation
          • 9.2.4.17.2.1 Formulation
          • 9.2.4.17.2.2 Indication
            • 9.2.4.17.2.2.1 Human Health
          • 9.2.4.17.2.3 Distribution Channel
      • 9.2.4.18 Bosnia Market
        • 9.2.4.18.1 Bosnia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.18.2 Bosnia: Colistin Market - By Segmentation
          • 9.2.4.18.2.1 Formulation
          • 9.2.4.18.2.2 Indication
            • 9.2.4.18.2.2.1 Human Health
          • 9.2.4.18.2.3 Distribution Channel
      • 9.2.4.19 Latvia Market
        • 9.2.4.19.1 Latvia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.19.2 Latvia: Colistin Market - By Segmentation
          • 9.2.4.19.2.1 Formulation
          • 9.2.4.19.2.2 Indication
            • 9.2.4.19.2.2.1 Human Health
          • 9.2.4.19.2.3 Distribution Channel
      • 9.2.4.20 Netherlands Market
        • 9.2.4.20.1 Netherlands: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.20.2 Netherlands: Colistin Market - By Segmentation
          • 9.2.4.20.2.1 Formulation
          • 9.2.4.20.2.2 Indication
            • 9.2.4.20.2.2.1 Human Health
          • 9.2.4.20.2.3 Distribution Channel
      • 9.2.4.21 Greece Market
        • 9.2.4.21.1 Greece: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.21.2 Greece: Colistin Market - By Segmentation
          • 9.2.4.21.2.1 Formulation
          • 9.2.4.21.2.2 Indication
            • 9.2.4.21.2.2.1 Human Health
          • 9.2.4.21.2.3 Distribution Channel
      • 9.2.4.22 Rest of Europe Market
        • 9.2.4.22.1 Rest of Europe: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.22.2 Rest of Europe: Colistin Market - By Segmentation
          • 9.2.4.22.2.1 Formulation
          • 9.2.4.22.2.2 Indication
            • 9.2.4.22.2.2.1 Human Health
          • 9.2.4.22.2.3 Distribution Channel
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Colistin Market Overview
    • 9.3.2 Asia Pacific: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.3.3 Asia Pacific: Colistin Market - By Segmentation
      • 9.3.3.1 Formulation
      • 9.3.3.2 Indication
        • 9.3.3.2.1 Human Health
      • 9.3.3.3 Distribution Channel
    • 9.3.4 Asia Pacific: Colistin Market Breakdown by Countries
      • 9.3.4.1 Australia and New Zealand Market
        • 9.3.4.1.1 Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.1.2 Australia and New Zealand: Colistin Market - By Segmentation
          • 9.3.4.1.2.1 Formulation
          • 9.3.4.1.2.2 Indication
            • 9.3.4.1.2.2.1 Human Health
          • 9.3.4.1.2.3 Distribution Channel
      • 9.3.4.2 Japan Market
        • 9.3.4.2.1 Japan: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.2.2 Japan: Colistin Market - By Segmentation
          • 9.3.4.2.2.1 Formulation
          • 9.3.4.2.2.2 Indication
            • 9.3.4.2.2.2.1 Human Health
          • 9.3.4.2.2.3 Distribution Channel
      • 9.3.4.3 Kazakhstan Market
        • 9.3.4.3.1 Kazakhstan: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.3.2 Kazakhstan: Colistin Market - By Segmentation
          • 9.3.4.3.2.1 Formulation
          • 9.3.4.3.2.2 Indication
            • 9.3.4.3.2.2.1 Human Health
          • 9.3.4.3.2.3 Distribution Channel
      • 9.3.4.4 Rest of APAC Market
        • 9.3.4.4.1 Rest of APAC: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.4.2 Rest of APAC: Colistin Market - By Segmentation
          • 9.3.4.4.2.1 Formulation
          • 9.3.4.4.2.2 Indication
            • 9.3.4.4.2.2.1 Human Health
          • 9.3.4.4.2.3 Distribution Channel
  • 9.4 Middle East and Africa
    • 9.4.1 Middle East and Africa Colistin Market Overview
    • 9.4.2 Middle East and Africa: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.4.3 Middle East and Africa: Colistin Market - By Segmentation
      • 9.4.3.1 Formulation
      • 9.4.3.2 Indication
        • 9.4.3.2.1 Human Health
      • 9.4.3.3 Distribution Channel
    • 9.4.4 Middle East and Africa: Colistin Market Breakdown by Countries
      • 9.4.4.1 Saudi Arabia Market
        • 9.4.4.1.1 Saudi Arabia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.4.4.1.2 Saudi Arabia: Colistin Market - By Segmentation
          • 9.4.4.1.2.1 Formulation
          • 9.4.4.1.2.2 Indication
            • 9.4.4.1.2.2.1 Human Health
          • 9.4.4.1.2.3 Distribution Channel
      • 9.4.4.2 Rest of Middle East and Africa Market
        • 9.4.4.2.1 Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.4.4.2.2 Rest of Middle East and Africa: Colistin Market - By Segmentation
          • 9.4.4.2.2.1 Formulation
          • 9.4.4.2.2.2 Indication
            • 9.4.4.2.2.2.1 Human Health
          • 9.4.4.2.2.3 Distribution Channel
  • 9.5 South and Central America
    • 9.5.1 South and Central America Colistin Market Overview
    • 9.5.2 South and Central America: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.5.3 South and Central America: Colistin Market - By Segmentation
      • 9.5.3.1 Formulation
      • 9.5.3.2 Indication
        • 9.5.3.2.1 Human Health
      • 9.5.3.3 Distribution Channel
    • 9.5.4 South and Central America: Colistin Market Breakdown by Countries
      • 9.5.4.1 Brazil Market
        • 9.5.4.1.1 Brazil: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.5.4.1.2 Brazil: Colistin Market - By Segmentation
          • 9.5.4.1.2.1 Formulation
          • 9.5.4.1.2.2 Indication
            • 9.5.4.1.2.2.1 Human Health
          • 9.5.4.1.2.3 Distribution Channel
      • 9.5.4.2 Rest of South and Central America Market
        • 9.5.4.2.1 Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.5.4.2.2 Rest of South and Central America: Colistin Market - By Segmentation
          • 9.5.4.2.2.1 Formulation
          • 9.5.4.2.2.2 Indication
            • 9.5.4.2.2.2.1 Human Health
          • 9.5.4.2.2.3 Distribution Channel

10. Colistin Market Industry Landscape

11. Colistin Market - Key Company Profiles

  • 11.1 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Norma Hellas S.A
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Apeloa Pharmaceutical Co., Ltd.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Livzon Pharmaceutical Group Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Shandong LuKang Pharmaceutical Co., Ltd
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Xellia Pharmaceuticals ApS
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Zhejiang Shenghua Biok Chemical Company Limited
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Fujian lifecome biochemistry Limited
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Tecoland Corporation
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 TZF Polfa S.A.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 Glossary
  • 12.2 Research Methodology and Approach
    • 12.2.1 Secondary Research
    • 12.2.2 Primary Research
    • 12.2.3 Market Estimation Approach
      • 12.2.3.1 Supply Side Analysis
      • 12.2.3.2 Demand Side Analysis
    • 12.2.4 Research Assumptions and Limitations
    • 12.2.5 Currency Conversion
  • 12.3 About The Insight Partners
  • 12.4 Market Intelligence Cloud

List Of Tables

  • Table 1. List of Regulatory Bodies and Organizations
  • Table 2. Ease of Doing Business: Key Country Rankings
  • Table 3. Market Entry Barriers
  • Table 4. CMS Vs Colistin Base Sulphate - Manufacturing & Commercial Assessment
  • Table 5. Global Tender Analysis
  • Table 6. Prevalence of Key 3 Diseases, By Region, 2024
  • Table 7. Pricing Analysis, ASPs of Key Products
  • Table 8. Global Colistin API Market Volume (Tonnes), 2025
  • Table 9. Global Colistin API Market Volume (Tonnes), 2025
  • Table 10. Pipeline Analysis of Next-Generation Polymyxins
  • Table 11. Market Share Analysis (%), 2025
  • Table 12. Colistin Market - Revenue, 2021-2025 (US$ Million)
  • Table 13. Colistin Market - Revenue Forecast, 2026-2034 (US$ Million)
  • Table 14. Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 15. Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 16. North America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 17. North America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 18. North America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 19. North America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 20. North America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 21. North America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 22. North America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 23. North America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 24. United States: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 25. United States: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 26. United States: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 27. United States: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 28. United States: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 29. United States: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 30. United States: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 31. United States: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 32. Canada: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 33. Canada: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 34. Canada: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 35. Canada: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 36. Canada: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 37. Canada: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 38. Canada: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 39. Canada: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 40. Mexico: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 41. Mexico: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 42. Mexico: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 43. Mexico: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 44. Mexico: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 45. Mexico: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 46. Mexico: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 47. Mexico: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 48. Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 49. Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 50. Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 51. Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 52. Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 53. Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 54. Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 55. Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 56. Germany: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 57. Germany: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 58. Germany: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 59. Germany: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 60. Germany: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 61. Germany: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 62. Germany: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 63. Germany: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 64. United Kingdom: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 65. United Kingdom: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 66. United Kingdom: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 67. United Kingdom: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 68. United Kingdom: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 69. United Kingdom: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 70. United Kingdom: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 71. United Kingdom: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 72. France: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 73. France: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 74. France: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 75. France: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 76. France: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 77. France: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 78. France: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 79. France: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 80. Italy: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 81. Italy: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 82. Italy: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 83. Italy: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 84. Italy: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 85. Italy: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 86. Italy: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 87. Italy: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 88. Spain: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 89. Spain: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 90. Spain: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 91. Spain: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 92. Spain: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 93. Spain: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 94. Spain: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 95. Spain: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 96. Poland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 97. Poland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 98. Poland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 99. Poland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 100. Poland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 101. Poland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 102. Poland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 103. Poland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 104. Romania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 105. Romania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 106. Romania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 107. Romania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 108. Romania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 109. Romania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 110. Romania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 111. Romania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 112. Serbia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 113. Serbia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 114. Serbia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 115. Serbia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 116. Serbia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 117. Serbia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 118. Serbia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 119. Serbia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 120. Bulgaria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 121. Bulgaria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 122. Bulgaria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 123. Bulgaria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 124. Bulgaria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 125. Bulgaria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 126. Bulgaria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 127. Bulgaria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 128. Czech Republic: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 129. Czech Republic: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 130. Czech Republic: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 131. Czech Republic: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 132. Czech Republic: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 133. Czech Republic: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 134. Czech Republic: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 135. Czech Republic: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 136. Belgium: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 137. Belgium: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 138. Belgium: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 139. Belgium: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 140. Belgium: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 141. Belgium: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 142. Belgium: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 143. Belgium: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 144. Slovakia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 145. Slovakia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 146. Slovakia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 147. Slovakia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 148. Slovakia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 149. Slovakia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 150. Slovakia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 151. Slovakia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 152. Ireland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 153. Ireland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 154. Ireland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 155. Ireland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 156. Ireland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 157. Ireland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 158. Ireland: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 159. Ireland: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 160. Hungary: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 161. Hungary: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 162. Hungary: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 163. Hungary: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 164. Hungary: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 165. Hungary: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 166. Hungary: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 167. Hungary: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 168. Portugal: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 169. Portugal: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 170. Portugal: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 171. Portugal: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 172. Portugal: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 173. Portugal: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 174. Portugal: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 175. Portugal: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 176. Lithuania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 177. Lithuania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 178. Lithuania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 179. Lithuania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 180. Lithuania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 181. Lithuania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 182. Lithuania: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 183. Lithuania: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 184. Austria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 185. Austria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 186. Austria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 187. Austria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 188. Austria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 189. Austria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 190. Austria: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 191. Austria: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 192. Bosnia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 193. Bosnia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 194. Bosnia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 195. Bosnia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 196. Bosnia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 197. Bosnia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 198. Bosnia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 199. Bosnia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 200. Latvia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 201. Latvia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 202. Latvia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 203. Latvia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 204. Latvia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 205. Latvia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 206. Latvia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 207. Latvia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 208. Netherlands: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 209. Netherlands: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 210. Netherlands: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 211. Netherlands: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 212. Netherlands: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 213. Netherlands: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 214. Netherlands: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 215. Netherlands: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 216. Greece: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 217. Greece: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 218. Greece: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 219. Greece: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 220. Greece: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 221. Greece: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 222. Greece: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 223. Greece: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 224. Rest of Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 225. Rest of Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 226. Rest of Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 227. Rest of Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 228. Rest of Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 229. Rest of Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 230. Rest of Europe: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 231. Rest of Europe: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 232. Asia Pacific: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 233. Asia Pacific: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 234. Asia Pacific: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 235. Asia Pacific: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 236. Asia Pacific: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 237. Asia Pacific: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 238. Asia Pacific: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 239. Asia Pacific: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 240. Australia and New Zealand: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 241. Australia and New Zealand: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 242. Australia and New Zealand: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 243. Australia and New Zealand: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 244. Australia and New Zealand: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 245. Australia and New Zealand: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 246. Australia and New Zealand: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 247. Australia and New Zealand: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 248. Japan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 249. Japan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 250. Japan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 251. Japan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 252. Japan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 253. Japan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 254. Japan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 255. Japan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 256. Kazakhstan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 257. Kazakhstan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 258. Kazakhstan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 259. Kazakhstan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 260. Kazakhstan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 261. Kazakhstan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 262. Kazakhstan: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 263. Kazakhstan: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 264. Rest of APAC: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 265. Rest of APAC: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 266. Rest of APAC: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 267. Rest of APAC: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 268. Rest of APAC: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 269. Rest of APAC: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 270. Rest of APAC: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 271. Rest of APAC: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 272. Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 273. Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 274. Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 275. Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 276. Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 277. Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 278. Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 279. Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 280. Saudi Arabia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 281. Saudi Arabia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 282. Saudi Arabia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 283. Saudi Arabia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 284. Saudi Arabia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 285. Saudi Arabia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 286. Saudi Arabia: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 287. Saudi Arabia: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 288. Rest of Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 289. Rest of Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 290. Rest of Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 291. Rest of Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 292. Rest of Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 293. Rest of Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 294. Rest of Middle East and Africa: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 295. Rest of Middle East and Africa: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 296. South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 297. South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 298. South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 299. South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 300. South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 301. South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 302. South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 303. South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 304. Brazil: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 305. Brazil: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 306. Brazil: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 307. Brazil: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 308. Brazil: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 309. Brazil: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 310. Brazil: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 311. Brazil: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 312. Rest of South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Formulation
  • Table 313. Rest of South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation
  • Table 314. Rest of South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Indication
  • Table 315. Rest of South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Indication
  • Table 316. Rest of South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Human Health
  • Table 317. Rest of South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Human Health
  • Table 318. Rest of South and Central America: Colistin Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 319. Rest of South and Central America: Colistin Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 320. Glossary - Colistin Market

List Of Figures

  • Figure 1. Colistin Market Segmentation.
  • Figure 2. Colistin Market - Value Chain Analysis
  • Figure 3. Porter's Five Forces Analysis
  • Figure 4. Pest Analysis
  • Figure 5. Colistin Market - Key Industry Dynamics
  • Figure 6. Impact Analysis of Drivers and Restraints
  • Figure 7. Colistin Market Revenue (US$ Million), 2021-2034
  • Figure 8. Colistin Market Share (%) - by Formulation (2025 and 2034)
  • Figure 9. Oral: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 10. Injectables (IV or IM): Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 11. Topical Formulations: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 12. Inhalation Solutions: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 13. Colistin Market Share (%) - by Indication (2025 and 2034)
  • Figure 14. Human Health: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 15. Human Health: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 16. Colistin Market Share (%) - by Distribution Channel (2025 and 2034)
  • Figure 17. Hospital Pharmacy: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 18. Retail Pharmacy: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 19. Online Channel: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 20. Other Distribution Channel: Colistin Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 21. North America: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 22. North America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 23. United States: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 24. Canada: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 25. Mexico: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 26. Europe: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 27. Europe: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 28. Germany: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 29. United Kingdom: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 30. France: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 31. Italy: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 32. Spain: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 33. Poland: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 34. Romania: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 35. Serbia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 36. Bulgaria: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 37. Czech Republic: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 38. Belgium: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 39. Slovakia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 40. Ireland: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 41. Hungary: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 42. Portugal: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 43. Lithuania: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 44. Austria: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 45. Bosnia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 46. Latvia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 47. Netherlands: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 48. Greece: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 49. Rest of Europe: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 50. Asia Pacific: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 51. Asia Pacific: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 52. Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 53. Japan: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 54. Kazakhstan: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 55. Rest of APAC: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 56. Middle East and Africa: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 57. Middle East and Africa: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 58. Saudi Arabia: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 59. Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 60. South and Central America: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 61. South and Central America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 62. Brazil: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 63. Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 64. Bottom-Up Approach and Top-Down Approach